MedTrace Logo

Assessment of Patient Satisfaction of Quality of Health Care Service and Treatment

NCT04048473 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 259

Last updated 2019-08-08

No results posted yet for this study

Summary

Patient satisfaction has become an important issue in the health services evaluation. It is equally important to medical results and economical costs of the provided services. Cancer is a common health problem frequently associated with pain that deserves patient satisfaction services. Assessment of patients' satisfaction in this sector of diseases is a cornerstone for optimum pain management. Recently, patient satisfaction is defined as personal evaluation of the experienced care, denoting both patient characteristics and care realities.

There are many questionnaires to assess patient satisfaction for health care service and treatment. For health service assessment, Patient Satisfaction Questionnaire Short Form (PSQ-18) is a commonly used one with high reliability. It includes seven dimensions of patient satisfaction which are general satisfaction, interpersonal manner, communication, technical quality, time spent with doctor, financial aspects, and accessibility and convenience.

With regard to patient satisfaction about the provided treatment, Pain Treatment Satisfaction Scale (PTSS) is routinely applied.

It is well known that any health care system needs continuous evaluation both by the care givers and patients in order to improve the quality of service. Of course, it is a continuous process with much variability. There are many studies about patient satisfaction in cancer patients., however this study is the first in Delta region, Egypt. From this point, the aim of this study is to evaluate the quality offered by health care services and the treatment satisfaction among cancer patients attending the outpatient pain management clinics, Mansoura, Egypt in two university centers.

Conditions

  • Satisfaction, Patient

Sponsors & Collaborators

  • Mansoura University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-09
Primary Completion
2019-08-01
Completion
2019-08-05

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04048473 on ClinicalTrials.gov